Purchase Order HHSN272201100704P
Award Date 7/27/11
Potential Completion Date 8/5/11
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products, to expand a high-fidelity PCR system for a large experiment requiring PCR amplification. The contract, with a ceiling value of $7,796.00, has a completion date of July 13, 2011. Roche Diagnostics is a global leader in diagnostic solutions, providing a wide...
- This is a $3,118.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The contract is for the expansion of high fidelity enzyme blends for the amplification of genomic DNA targets. The contract has no set-aside designation, indicating it was competed openly. Roche Diagnostics is a global leader in diagnostic solutions...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $3,118.40 firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The contract is for PCR kits, with an ultimate completion date of October 17, 2012. Roche Diagnostics has held various federal contracts and subcontracts to provide medical equipment, reagents, and...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Roche Diagnostics Corporation to expand a high-fidelity polymerase chain reaction (PCR) system for genomic testing. The $3,118.40 contract has an ultimate completion date of January 23, 2012 and did not utilize a small business set-aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics,...
- This federal contract award to Roche Diagnostics Corporation is for 1 year of service and support for a next generation sequencer. The $50,000.00 firm fixed price contract was awarded on September 23, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services. The contract does not have a set-aside designation, indicating Roche competed openly for the award. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
- This federal contract award was made by the U.S. Department of Health and Human Services to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $10,045.51 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for drugs and biologicals, with an ultimate completion date of December 31, 2014. The contract is not designated as a set-aside. Roche...
- This federal contract award was made by the Office of the Director, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $22,825.44 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of December 31, 2013. The contract is not designated as a set-aside. Roche Diagnostics holds multiple significant...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price (FFP) pricing type, has a ceiling value of $6,525.40 and was awarded on August 2, 2013 by the Office of the Chief Operating Officer, a civilian federal agency. The contract does not have a set-aside...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price pricing type, has a ceiling value of $9,572.64 and was awarded on February 7, 2014 by the Office of the Chief Operating Officer, a civilian federal agency. The contract is for the delivery of...
- This federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, provides $8,119.14 in firm fixed-price funding for medical drugs and biologicals. The contract was awarded on March 12, 2015 by the Office of the Director, a civilian federal agency, with a completion date of December 31, 2015. Roche Diagnostics, the prime contractor, has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs)...